EMAIL DETAILS
SUBJECT:
Re: In DC this week
PRI: NORMAL
FROM:
M
msolimene@ovationbiotech.com
DATE:
2012-04-03 10:45:53
MSG_ID:
<-9052805682519279521@unknownmsgid>
RECIPIENTS:
TO:
E
Eric Schwerin
<eschwerin@rosemontseneca.com>
CC:
H
Hunter Biden
<hbiden@rosemontseneca.com>
L
Laird Bunch
<lbunch@bfpsir.com>
N
Neil Callahan
<ncallahan@rosemontseneca.com>
R
rwalker@rosemontseneca.com
CONTENT:
TEXT: YES |
HTML: NO
PROCESSED
Eric, Absolutely we can have a call next week mon or tues or the following week of the 16th anytime. I am in Toronto next Wed - Fri negotiating a JV with the largest biodiesel company in Canada who wants to build their next refinery in partnership with us in the USA (they sell 100% of their Canadian made fuel in the US). Please feel free to suggest a time that suits you best. I look forward to sharing our progress with you. Best regards, Michael Michael Solimene Chief Executive Officer Ovation Biotech, Inc 919-526-0269 Please note my new email address msolimene@ovationbiotech.com On Apr 2, 2012, at 9:21 PM, Eric Schwerin <eschwerin@rosemontseneca.com> wrote: > Michael- > > That all sounds exciting and I am glad it wasn't Laird that you named > as your COO. > > Hunter is just getting back from a week away for Spring Break with his > family and we are consequently trying to squeeze two weeks into one > this week. Can we catch up by phone in the next week or two after we > get through this week? Rob is out of the country this week as well > and I'd like him to be on the call as well. > > Let us know what your schedule is like next week or the week after next. > > Best, > > Eric > > Sent from my iPad > > On Apr 2, 2012, at 9:07 AM, Michael Solimene > <msolimene@ovationbiotech.com> wrote: > >> Hunter, >> My apologies I did not give you more advanced notice - but I am in DC >> this week at the Advanced Biofuels Leadership Conference. Since we >> last met, I have made some strong progress in commercial partnerships >> and would welcome the opportunity to share with you, Eric, Rob or Neil >> if anyone has time this week. >> >> We are negotiating with two publicly listed fuel companies for JV >> agreements focused on our patented technology. Additionally I brought >> on a new COO, a very skillful guy i have known for 15+ years, who is >> focused on the enzyme side of our business. We believe the enzyme >> business has a margin potential far in excess of the fuels business an >> a very quick time to market for high value products. >> >> If you and/or the team have some time, I will gladly come over to >> Georgetown for a quick update. >> >> Also- completed the company rebranding - we are now Ovation Biotech, Inc. >> >> Best regards, >> >> Michael >> >> Michael Solimene >> Chief Executive Officer >> Ovation Biotech, Inc >> 919-526-0269 >> >> Please note my new email address msolimene@ovationbiotech.com
METADATA:
THREAD:
INDEX:
AdhhoK/V9HCanTDqSu2alHG11MQGLg==
REFERENCES:
REPLY_TO:
<-2413103984251311662@unknownmsgid>
REFS:
<199320214425588229@unknownmsgid>
<-2413103984251311662@unknownmsgid>